AAOpt 2024: Racial and socioeconomic disparities in diabetic eye disease

News
Video

A. Paul Chous, MA, OD, FAAO, details a presentation on this year's updates on diabetes given at this year's Academy meeting.

Paul Chous, MA, OD, FAAO, overviews a presentation he gave at the 2024 American Academy of Optometry meeting alongside Jeffry Gerson, OD, FAAO. Chous explains that the presentation will focus on several key updates in diabetes care, including a greater emphasis on racial and socioeconomic disparities in diabetic eye disease. One major topic is the impact of glucagon-like peptide-1 receptor agonist medications, which are commonly used for weight loss and type 2 diabetes management. Chous notes that while these drugs have shown benefits like reduced sleep apnea and dementia risk, there are also concerns that they may worsen diabetic retinopathy in some patients, particularly those who experience rapid improvements in blood glucose levels. The presentation also covered emerging therapies for diabetic retinopathy, including the use of electroretinography to monitor disease progression, as well as potential oral medications and gene therapies that may help slow the worsening of diabetic eye disease.

Additionally, Chous discussed the importance of cardiovascular and renal protection for patients with diabetes, as these comorbidities are often more life-threatening than vision loss. He emphasizes that optometrists should be familiar with these broader diabetes management strategies, as they can impact ocular health. Overall, the presentation aims to provide optometrists with a comprehensive update on the rapidly evolving landscape of diabetes care, with a focus on identifying high-risk patients, utilizing new diagnostic tools, and understanding emerging treatment options that can help preserve vision and overall health for individuals living with diabetes.

Recent Videos
Walline, OD, PhD, FAAO, outlines how to predict myopia progression and delay its onset in an exclusive interview with Optometry Times.
Jeffrey Walline, OD, PhD, FAAO, overviews a presentation he gave on the Bifocal Lenses in Nearsighted Kids 2 (BLINK2) cohort study at the Collaborative Community on Ophthalmic Innovation (CCOI).
Danica Marrelli, OD, FAAO, at Glaucoma 360 discussing visual field testing for patients with glaucoma
Walline, OD, PhD, FAAO, states that the best way to learn the benefits of artificial intelligence for your practice is to stay on top of continuing education attendance.
Jeffrey Walline, OD, PhD, FAAO, gives an overview of the AAO's 2024 and what to expect in 2025 and beyond.
Abby Gillogly Harsch, OD, FAAO, FSLS, shares a specific complex case of scleral lens fitting that she presented on at this year's GSLS.
Sherrol Reynolds, OD, FAAO, values the ophthalmic-optometric collaboration on display at the summit, running from February 14-17, 2025 in San Juan, Puerto Rico.
Katie Rachon, OD, FAAO, Dipl ABO, shares her excitement for the upcoming conference and what it means for an optometrist's toolbox.
EnVision Summit Cochair Cecelia Koetting, OD, FAAO, Dipl ABO, says that attendees should get ready for more discussion-based panels at this year's conference.
From contact lens dropout to addressing diabetic retinopathy in rural communities, optometrists choose an area of eye care research that they would expand, given the appropriate resources.
© 2025 MJH Life Sciences

All rights reserved.